Yezan Munther Haddadin - Net Worth and Insider Trading
Yezan Munther Haddadin Net Worth
The estimated net worth of Yezan Munther Haddadin is at least $8,583 dollars as of 2024-12-27. Yezan Munther Haddadin is the Director of Outlook Therapeutics Inc and owns about 5,049 shares of Outlook Therapeutics Inc (OTLK) stock worth over $8,583. Details can be seen in Yezan Munther Haddadin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yezan Munther Haddadin has not made any transactions after 2024-03-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Yezan Munther Haddadin
Yezan Munther Haddadin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yezan Munther Haddadin owns 1 companies in total, including Outlook Therapeutics Inc (OTLK) .
Click here to see the complete history of Yezan Munther Haddadin’s form 4 insider trades.
Insider Ownership Summary of Yezan Munther Haddadin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2024-03-28 | director |
Yezan Munther Haddadin Latest Holdings Summary
Yezan Munther Haddadin currently owns a total of 1 stock. Yezan Munther Haddadin owns 5,049 shares of Outlook Therapeutics Inc (OTLK) as of March 28, 2024, with a value of $8,583.
Latest Holdings of Yezan Munther Haddadin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2024-03-28 | 5,049 | 1.70 | 8,583 |
Holding Weightings of Yezan Munther Haddadin
Yezan Munther Haddadin Form 4 Trading Tracker
According to the SEC Form 4 filings, Yezan Munther Haddadin has made a total of 5 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Outlook Therapeutics Inc is the acquisition of 1,882 shares on March 28, 2024, which cost Yezan Munther Haddadin around $22,242.
Insider Trading History of Yezan Munther Haddadin
- 1
Yezan Munther Haddadin Trading Performance
GuruFocus tracks the stock performance after each of Yezan Munther Haddadin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yezan Munther Haddadin is 23.85%. GuruFocus also compares Yezan Munther Haddadin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yezan Munther Haddadin within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Yezan Munther Haddadin's insider trading performs compared to the benchmark.
Performance of Yezan Munther Haddadin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.96 | | | | | |
| Relative Return to S&P 500(%) | -3.72 | | | | | |
Yezan Munther Haddadin Ownership Network
Yezan Munther Haddadin Owned Company Details
What does Outlook Therapeutics Inc do?
Who are the key executives at Outlook Therapeutics Inc?
Yezan Munther Haddadin is the director of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include CFO and Secretary Lawrence A Kenyon , Chief Commercial Officer Jeff Evanson , and Chief Operating Officer Terry Dagnon .
Outlook Therapeutics Inc (OTLK) Insider Trades Summary
Over the past 18 months, Yezan Munther Haddadin made 1 insider transaction in Outlook Therapeutics Inc (OTLK) with a net purchase of 1,882. Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net purchase of 62,484 shares made by Jeff Evanson , a net purchase of 5,000 shares made by Lawrence A Kenyon ,
In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Outlook Therapeutics Inc (OTLK) were sold and 10,006 shares were bought by its insiders, resulting in a net purchase of 10,006 shares.
Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Outlook Therapeutics Inc Insider Transactions
Yezan Munther Haddadin Mailing Address
Above is the net worth, insider trading, and ownership report for Yezan Munther Haddadin. You might contact Yezan Munther Haddadin via mailing address: Zahran Street, 7th Circle Zahran Plaza, 4th Floor, Po Box 142904, Amman M2 11844.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
